OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Dr Chanock is a leading expert in the discovery and characterisation of cancer susceptibility regions in the human genome. He has received numerous awards for his scientific contributions to our understanding of common inherited genetic variants associated with cancer risk and outcomes. Dr Chanock received his M.D. from Harvard Medical School and completed clinical training at Boston Children’s Hospital and the Dana-Farber Cancer Institute, Boston. From 2001-7, he was a tenured investigator in the Genomic Variation Section of the Pediatric Oncology Branch in the NCI Center for Cancer Research and also served as co-chair of NCI’s Genetics, Genomics and Proteomics Faculty. In 2001, he was appointed as Chief of the Cancer Genomics Research Laboratory, and in 2007 as Chief of the Laboratory of Translational Genomics, both within DCEG. From 2012-3, he served as Acting Co-Director of the NCI Center for Cancer Genomics and was appointed Director of DCEG in 2013. Since 1995, Dr Chanock has served as the Medical Director for Camp Fantastic, a week-long recreational camp for paediatric cancer patients.
